From Spiradenocarcinoma to Spiradenoma: A Case of Histopathological Diagnostic Reclassification
- 1Surgery, Hospital São Lucas da PUCRS, Porto Alegre, BRA
- 2General Practice, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, BRA
Abstract
Spiradenocarcinoma is a rare malignant cutaneous adnexal neoplasm that may arise from a preexisting spiradenoma. Distinguishing benign from malignant lesions can be challenging, and diagnostic classification has important implications for treatment and follow-up.
A 37-year-old woman presented with an approximately 3-cm erythematous-violaceous nodule on the right ankle that had been present for five years and had recently grown rapidly. The initial histopathological assessment described a malignant epithelial neoplasm compatible with spiradenocarcinoma associated with a benign spiradenoma component. The patient underwent wider surgical re-excision with clinical margins exceeding 1 cm, and computed tomography of the chest, abdomen, and pelvis showed no metastatic disease. No residual neoplasm was identified in the re-excision specimen. Subsequent review of the original histological slides at a second laboratory identified a well-circumscribed, lobulated, solid-cystic dermal lesion with two distinct epithelial cell populations and an interspersed lymphocytic infiltrate, without infiltrative growth, nuclear atypia, mitotic activity, or necrosis in the reviewed material. The diagnosis was revised to benign spiradenoma. Immunohistochemistry supported the diagnosis of an eccrine neoplasm.
This case illustrates the diagnostic challenges in distinguishing spiradenoma from spiradenocarcinoma and the clinical implications of discrepant histopathological assessments. Morphological evaluation remains central to classification, while immunohistochemistry provides complementary information.
Related
- Clinical and histopathological patterns of American cutaneous leishmaniasis: diagnostic and therapeutic implications for targeted therapy
- Giant Pelvic Cyst Mimicking a Para-Ovarian Cyst: A Diagnostic Challenge With Successful Surgical Excision and Histopathological Correlation.
- A Rare Suprasellar Ependymoma With Negative Targeted Fusion Testing: Diagnostic Value of Histopathological, Immunohistochemical, and Ultrastructural Findings.
- Pheochromocytomas with Aggressive Histopathological Features Have Reduced Apelin and Increased VEGF Expression: Diagnostic and Prognostic Implications.
- Diagnostic Accuracy of Fine Needle Aspiration Cytology in Thyroid Diseases: Comparison with Histopathological Findings in Hawassa, Ethiopia
BibTeX
@article{bressani2026from,
title = {{From Spiradenocarcinoma to Spiradenoma: A Case of Histopathological Diagnostic Reclassification}},
author = {Renata F Bressani and Laura C Barazzetti and Raíssa Kalsing and Vitória C Vieira},
journal = {Cureus},
year = {2026},
month = nov,
doi = {10.7759/cureus.119048},
url = {https://europepmc.org/article/PMC/PMC13729697},
note = {CC BY},
}
RIS
TY - JOUR
TI - From Spiradenocarcinoma to Spiradenoma: A Case of Histopathological Diagnostic Reclassification
AU - Renata F Bressani
AU - Laura C Barazzetti
AU - Raíssa Kalsing
AU - Vitória C Vieira
PY - 2026
DA - 2026/11/03
JO - Cureus
DO - 10.7759/cureus.119048
UR - https://europepmc.org/article/PMC/PMC13729697
AB - Spiradenocarcinoma is a rare malignant cutaneous adnexal neoplasm that may arise from a preexisting spiradenoma. Distinguishing benign from malignant lesions can be challenging, and diagnostic classification has important implications for treatment and follow-up. A 37-year-old woman presented with an approximately 3-cm erythematous-violaceous nodule on the right ankle that had been present for five years and had recently grown rapidly. The initial histopathological assessment described a malignant epithelial neoplasm compatible with spiradenocarcinoma associated with a benign spiradenoma component. The patient underwent wider surgical re-excision with clinical margins exceeding 1 cm, and computed tomography of the chest, abdomen, and pelvis showed no metastatic disease. No residual neoplasm was identified in the re-excision specimen. Subsequent review of the original histological slides at a second laboratory identified a well-circumscribed, lobulated, solid-cystic dermal lesion with two distinct epithelial cell populations and an interspersed lymphocytic infiltrate, without infiltrative growth, nuclear atypia, mitotic activity, or necrosis in the reviewed material. The diagnosis was revised to benign spiradenoma. Immunohistochemistry supported the diagnosis of an eccrine neoplasm. This case illustrates the diagnostic challenges in distinguishing spiradenoma from spiradenocarcinoma and the clinical implications of discrepant histopathological assessments. Morphological evaluation remains central to classification, while immunohistochemistry provides complementary information.
SN - 2168-8184
ER -